DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia

DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia

Objectives: Dual specificity phosphatase 1 (DUSP1) is high-expressed in various cancers and plays an important role in the cellular response to agents that damage DNA. We aimed to investigate the expressions and mechanisms of DUSP1 signaling pathway regulating cytarabine (Ara-C) resistance in acute...

Full description

Bibliographic Details
Main Authors:	Huali Sun MD, Yanling Ren MD, Xinping Zhou MD, Qi Chen MS, Yanmei Liu MD, Chumeng Zhu MS, Yanyun Ruan MS, Hongli Ruan MD, Hongyan Tong MD, Shenpeng Ying MD, Peipei Lin MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-10-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/15330338231207765

Similar Items

An Uncommon Case of Upper-Extremity Mucormycosis in a Patient With Acute Myeloid Leukemia
by: Teren Yedikian, MS, BS, et al.
Published: (2024-01-01)

Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine
by: Nienke Visser, et al.
Published: (2021-02-01)

Educational Case: Myeloid Sarcoma: A Subtype of Acute Myeloid Leukemia
by: Ananya Datta Mitra MD, et al.
Published: (2020-09-01)

Educational Case: Chronic Myeloid Leukemia
by: Britni R. E. Bryant MD, et al.
Published: (2019-12-01)

Acute Myeloid Leukemia With Presenting as Severe Hepatic Failure
by: Yoshiko Nakano MD, et al.
Published: (2017-01-01)

Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia
by: Tao Zhang, et al.
Published: (2024-01-01)

Intertriginous maculopapular mastocytosis in a patient with acute myeloid leukemia
by: María Herrero-Moyano, MD, et al.
Published: (2017-01-01)

Diffuse purpuric eruption in a patient with acute myeloid leukemia
by: Zoha K. Momin, BS, et al.
Published: (2023-11-01)

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
by: Rebecca Anderson, et al.
Published: (2022-03-01)

Sequential treatment with cytarabine and decitabine has an increased anti-leukemia effect compared to cytarabine alone in xenograft models of childhood acute myeloid leukemia.
by: Sarah M Leonard, et al.
Published: (2014-01-01)

Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis
by: Emily B. Wolf MD, et al.
Published: (2023-11-01)

Papular eruption after induction chemotherapy for acute myeloid leukemia
by: Taylor Novice, BS, et al.
Published: (2020-02-01)

The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia
by: Chun-Jin Peng MD, et al.
Published: (2024-01-01)

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
by: Baohang Zhang, et al.
Published: (2023-05-01)

Extramedullary relapse of acute myeloid leukemia in the breast: A radiological case report
by: Anna Fairfax, MD, et al.
Published: (2024-05-01)

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia
by: Mayur D. Mody MD, et al.
Published: (2017-02-01)

DUSP1 Blocks autophagy-dependent ferroptosis in pancreatic cancer
by: Yangchun Xie, et al.
Published: (2020-09-01)

Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies
by: Natthaporn Sasijareonrat MD, et al.
Published: (2020-06-01)

TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response
by: Yigit Sener MD, et al.
Published: (2019-06-01)

Bullous drug eruption with leukemic cell infiltrate in the setting of new-onset acute myeloid leukemia
by: Trisha Khanna, BS, et al.
Published: (2017-11-01)

Breast manifestation of extramedullary myeloid sarcoma: A case report
by: Saba Naamo, MD, et al.
Published: (2022-12-01)

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
by: Nizar Serhan, et al.
Published: (2020-06-01)

Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
by: Qingguo Liu, et al.
Published: (2020-07-01)

Safety and Feasibility of Outpatient High Dose Cytarabine for Acute Myeloid Leukemia in the Brazilian Amazon
by: Amanda Lopes Maia Rodrigues, et al.
Published: (2020-07-01)

Corneal epithelial microcysts due to high dose Cytarabine administration in acute myeloid leukemia
by: Tuba Hilkay Karapınar, et al.
Published: (2012-03-01)

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
by: Sook-Kyoung Heo, et al.
Published: (2020-12-01)

Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
by: Rie Nishi, et al.
Published: (2020-10-01)

Systolic Strain by Speckle-Tracking Echocardiography Is a Feasible and Sensitive Measure of Right Ventricular Dysfunction in Acute Respiratory Failure Patients on Mechanical Ventilation
by: James Simmons, MD, et al.
Published: (2022-01-01)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
by: Miguel Carracedo, PhD, et al.
Published: (2020-03-01)

Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management
by: Stella X. Chen, MD, et al.
Published: (2022-01-01)

A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib
by: Alexis Tracy, MD, et al.
Published: (2022-12-01)

A Case of Recurrent Myocarditis After COVID-19 Vaccination, Due to Acute Myeloid LeukemiaNovel Teaching Points
by: Isabelle Dobronyi, MD, et al.
Published: (2022-12-01)

Deep cutaneous candidiasis of the lip in a patient with acute myelogenous leukemia
by: Jose L. Cortez, MD, MS, et al.
Published: (2022-09-01)

Higher Expression of With Lower Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia
by: Cunte Chen MD, et al.
Published: (2021-11-01)

De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ
by: Edward Nabrinsky, MD, et al.
Published: (2021-01-01)

EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients
by: Feiyue Zhu MD, et al.
Published: (2021-10-01)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
by: Gabriela Rodríguez-Macías, et al.
Published: (2023-06-01)

Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia
by: Sonali P. Barwe, et al.
Published: (2022-02-01)

Artesunate reverses cytarabine resistance in acute myeloid leukemia by blocking the JAK/STAT3 signaling
by: Qiong Su, et al.
Published: (2023-12-01)

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
by: Stefan Hatzl, et al.
Published: (2020-02-01)